Braemar Hotels & Resorts (BHR) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
8 Jul, 2026Executive summary
Achieved 1.9% comparable RevPAR growth in Q4 2024 after six quarters of decline, with ADR up 0.4% to $480 and occupancy up 1.5% to 63.5%.
Strong group revenue growth (7% in Q4), with urban hotels showing 3.3% RevPAR growth and January 2025 portfolio RevPAR up 13% year-over-year.
Completed major renovations and capital projects at key properties, enhancing guest experience and driving incremental revenue.
Redeemed $80 million of non-traded preferred stock, representing 17% of the original capital raise, as part of shareholder value creation.
Strong liquidity with $135.5 million in cash and $49.6 million in restricted cash at year-end.
Financial highlights
Q4 2024 net loss attributable to common stockholders was $31.1 million ($0.47 per diluted share); AFFO per diluted share was negative $0.06.
Full year 2024 net loss attributable to common stockholders was $50.9 million ($0.77 per diluted share); AFFO per diluted share was $0.21.
Adjusted EBITDA was $30.2 million for Q4 and $157.6 million for the full year.
Capex was $15.8 million in Q4 and $70.6 million for the year.
Quarterly dividend maintained at $0.05 per share (annualized yield of 7.7%).
Outlook and guidance
Strong forward booking pace for 2025, with group rooms revenue pacing 8% ahead of prior year.
Management expects continued momentum in 2025, citing strong forward bookings, improving industry fundamentals, and supply constraints.
Portfolio is positioned to benefit from potential interest rate cuts, which would lower debt costs and improve cash flow.
Expect continued steady growth in resort segment due to low supply growth and high barriers to entry.
Capital expenditures projected at $75–$95 million for 2025, focused on luxury enhancements.
Latest events from Braemar Hotels & Resorts
- Transition to self-management and board overhaul gains investor backing amid governance scrutiny.BHR
Proxy filing22 Jul 2026 - Q1 2025 delivered 4.2% RevPAR growth, EBITDA gains, and key debt refinancing.BHR
Q1 20258 Jul 2026 - Record AFFO per share, strong EBITDA growth, and a $176M asset sale highlight Q1 2026.BHR
Q1 202612 May 2026 - 2025 saw modest RevPAR growth, net loss, and a sale process, with resorts outperforming.BHR
Q4 20253 Mar 2026 - Urban hotels outperformed as asset sales and refinancing strengthened the balance sheet.BHR
Q2 20242 Feb 2026 - Urban hotels outperformed as asset sales and refinancing strengthened liquidity.BHR
Q3 202415 Jan 2026 - Luxury hotel REIT expects higher cash flow and rates as supply tightens and demand rebounds.BHR
Sidoti Micro-Cap Virtual Conference9 Jan 2026 - Virtual annual meeting faces legal challenge over board nominations and voting procedures.BHR
Proxy Filing8 Dec 2025 - Board urges support for its nominees and proposals amid proxy contest and governance focus.BHR
Proxy Filing1 Dec 2025